IBM Retirement Fund’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
Other funds holding HZNP
N
PC
ACA
IBM Retirement Fund's HZNP Position: Q2 2022 in Review
IBM Retirement Fund sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q2 2022, closing a stake of 3,482 shares — an estimated $366K sold.
IBM Retirement Fund first reported a position in HZNP in Q2 2020 and held it in 8 quarters. The position peaked at $677K in Q3 2021. 616 funds tracked by Wall St. Rank hold HZNP as of Q2 2022.
- IBM Retirement Fund reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q2 2022 after selling out during the quarter.
- IBM Retirement Fund sold 3,482 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q2 2022, an estimated $366K.
- IBM Retirement Fund first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2020 and held it in 8 quarters.
- IBM Retirement Fund's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $677K in Q3 2021.
- 616 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2022.
Based on IBM Retirement Fund's 13F filing for Q2 2022, filed 20 Jul 2022.